Related references
Note: Only part of the references are listed.Ataluren and aminoglycosides stimulate read-through of nonsense codons by orthogonal mechanisms
Martin Y. Ng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Translational readthrough of ciliopathy genes BBS2 and ALMS1 restores protein, ciliogenesis and function in patient fibroblasts
Jonathan Eintracht et al.
EBIOMEDICINE (2021)
Efficacy and safety of ataluren in patients with nonsense-mutation cystic fibrosis not receiving chronic inhaled aminoglycosides: The international, randomized, double-blind, placebo-controlled Ataluren Confirmatory Trial in Cystic Fibrosis (ACT CF)
M. W. Konstan et al.
JOURNAL OF CYSTIC FIBROSIS (2020)
Nonsense suppression induced readthrough of a novel PAX6 mutation in patient-derived cells of congenital aniridia
Xiaoliang Liu et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2020)
Stop codon context influences genome-wide stimulation of termination codon readthrough by aminoglycosides
Jamie R. Wangen et al.
ELIFE (2020)
Safety and effectiveness of ataluren: comparison of results from the STRIDE Registry and CINRG DMD Natural History Study
Eugenio Mercuri et al.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH (2020)
Heterozygous missense variant in EIF6 gene: A novel form of Shwachman–Diamond syndrome?
Ai Ling Koh et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2020)
Targeting Nonsense: Optimization of 1,2,4-Oxadiazole TRIDs to Rescue CFTR Expression and Functionality in Cystic Fibrosis Cell Model Systems
Ivana Pibiri et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Deciphering the Nonsense Readthrough Mechanism of Action of Ataluren: An in Silico Compared Study
Marco Tutone et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Ataluren-driven restoration of Shwachman-Bodian-Diamond syndrome protein function in Shwachman-Diamond syndrome bone marrow cells
Valentino Bezzerri et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Diagnosis, Treatment, and Molecular Pathology of Shwachman-Diamond Syndrome
Adam S. Nelson et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2018)
Rescuing the CFTR protein function: Introducing 1,3,4-oxadiazoles as translational readthrough inducing drugs
Ivana Pibiri et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Off-Label Use of Ataluren in Four Non-ambulatory Patients With Nonsense Mutation Duchenne Muscular Dystrophy: Effects on Cardiac and Pulmonary Function and Muscle Strength
Daniel Ebrahimi-Fakhari et al.
FRONTIERS IN PEDIATRICS (2018)
One-year follow up of three Italian patients with Duchenne muscular dystrophy treated with ataluren: is earlier better?
Lucia Ruggiero et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2018)
Mutations in signal recognition particle SRP54 cause syndromic neutropenia with Shwachman-Diamond-like features
Raphael Carapito et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Mutations in EFL1, an SBDS partner, are associated with infantile pancytopenia, exocrine pancreatic insufficiency and skeletal anomalies in a Shwachman-Diamond like syndrome
Polina Stepensky et al.
JOURNAL OF MEDICAL GENETICS (2017)
Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Craig M. McDonald et al.
LANCET (2017)
Aminoglycoside interactions and impacts on the eukaryotic ribosome
Irina Prokhorova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Efficacy of Postnatal In Vivo Nonsense Suppression Therapy in a Pax6 Mouse Model of Aniridia
Xia Wang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Tissue-specific variation in nonsense mutant transcript level and drug-induced read-through efficiency in the Cln1R151X mouse model of INCL
Vaughn Thada et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
Exploring the readthrough of nonsense mutations by non-acidic Ataluren analogues selected by ligand-based virtual screening
Ivana Pibiri et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Functional rescue of REP1 following treatment with PTC124 and novel derivative PTC-414 in human choroideremia fibroblasts and the nonsense-mediated zebrafish model
Mariya Moosajee et al.
HUMAN MOLECULAR GENETICS (2016)
Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression
Bijoyita Roy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
New insights into the Shwachman-Diamond Syndrome-related haematological disorder: hyper-activation of mTOR and STAT3 in leukocytes
Valentino Bezzerri et al.
SCIENTIFIC REPORTS (2016)
Immunophenotypic analysis of hematopoiesis in patients suffering from Shwachman-Bodian-Diamond Syndrome
Angela Mercuri et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2015)
Enhancement of premature stop codon readthrough in the CFTR gene by Ataluren (PTC124) derivatives
Ivana Pibiri et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Muscle dysfunction and structural defects of dystrophin-null sapje mutant zebrafish larvae are rescued by ataluren treatment
Mei Li et al.
FASEB JOURNAL (2014)
Toward a Rationale for the PTC124 (Ataluren) Promoted Readthrough of Premature Stop Codons: A Computational Approach and GFP-Reporter Cell-Based Assay
Laura Lentini et al.
MOLECULAR PHARMACEUTICS (2014)
Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial
Elton Kerem et al.
LANCET RESPIRATORY MEDICINE (2014)
Phase 2a Study of Ataluren-Mediated Dystrophin Production in Patients with Nonsense Mutation Duchenne Muscular Dystrophy
Richard S. Finkel et al.
PLOS ONE (2013)
A Lack of Premature Termination Codon Read-Through Efficacy of PTC124 (Ataluren) in a Diverse Array of Reporter Assays
Stuart P. McElroy et al.
PLOS BIOLOGY (2013)
Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome
Jean Donadieu et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group
T. M. Westers et al.
LEUKEMIA (2012)
Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis
M. Wilschanski et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Ataluren (PTC124) Induces Cystic Fibrosis Transmembrane Conductance Regulator Protein Expression and Activity in Children with Nonsense Mutation Cystic Fibrosis
Isabelle Sermet-Gaudelus et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Repairing faulty genes by aminoglycosides: Development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations
Igor Nudelman et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes
Arjan A. van de Loosdrecht et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial
Eitan Kerem et al.
LANCET (2008)
Flow cytometry in myelodysplastic syndromes: Report from a working conference
Michael R. Loken et al.
LEUKEMIA RESEARCH (2008)
Morphological and cytofluorimetric analysis of adult mesenchymal stem cells expanded ex vivo from periodontal ligament
O Trubiani et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2005)
Cadmium-induced ectopic apoptosis in zebrafish embryos
PK Chan et al.
ARCHIVES OF TOXICOLOGY (2003)
Mutations in SBDS are associated with Shwachman-Diamond syndrome
GRB Boocock et al.
NATURE GENETICS (2003)
Shwachman-Diamond syndrome marrow cells show abnormally increased apoptosis mediated through the Fas pathway
Y Dror et al.
BLOOD (2001)
Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system
M Manuvakhova et al.
RNA (2000)
Share Paper
